Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage

R Al-Shahi Salman, SM Greenberg - Stroke, 2023 - Am Heart Assoc
This focused update about antiplatelet agents to reduce the high risk of major adverse
cardiovascular events after stroke due to spontaneous (nontraumatic) intracerebral …

Role of O-GlcNAcylation in Central Nervous System Development and Injuries: A Systematic Review

L Zhang, W Bai, Y Peng, Y Lin, M Tian - Molecular Neurobiology, 2024 - Springer
The development of central nervous system (CNS) can form perceptual, memory, and
cognitive functions, while injuries to CNS often lead to severe neurological dysfunction and …

Relationship between coagulopathy score and ICU mortality: analysis of the MIMIC-IV database

Z Xie, S Zhu, J Wang, M Zhang, X Lv, Y Ma, H Shan… - Heliyon, 2024 - cell.com
Objective Coagulopathy score has been applied as a new prognostic indicator for sepsis,
heart failure and acute respiratory failure. However, its ability to forecast intensive care unit …

[PDF][PDF] Risk and benefit of reinitiating antiplatelet therapy after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.

JW Zhang, JX Zhao, GF Yin - European Review for Medical & …, 2024 - europeanreview.org
OBJECTIVE: This study aimed to assess the risks and benefits of reinitiating antiplatelet
therapy after spontaneous intracerebral hemorrhage (ICH) through a systematic review and …

Hubungan Konsumsi Antiplatelet Dengan Kejadian Perdarahan Intrakranial

FD Tamara - Health Information: Jurnal Penelitian, 2023 - myjurnal.poltekkes-kdi.ac.id
Antiplatelet therapy is increasingly being used for secondaryprevention of cardiovascular
disease and reducing the risk of recurrentischemic events. The use of antiplatelets is often …